Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Litton

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Cancers|October 14, 2023
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast CancerZhan Xu, David E Rauch, Rania M Mohamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEPJennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Molecular Cell|August 18, 2018
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Cancers|February 25, 2023
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRIBikash Panthi, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 31, 2024
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic TherapyBenjamin C Musall, David E Rauch, Rania M M Mohamed, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Cancers|October 14, 2023
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast CancerZhan Xu, David E Rauch, Rania M Mohamed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEPJennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Molecular Cell|August 18, 2018
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.
Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Cancers|February 25, 2023
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRIBikash Panthi, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 31, 2024
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic TherapyBenjamin C Musall, David E Rauch, Rania M M Mohamed, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
Pageof 16